Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Bi-directional nasal delivery of aerosols can prevent lung deposition.

Djupesland PG, Skretting A, Winderen M, Holand T.

J Aerosol Med. 2004 Fall;17(3):249-59.

PMID:
15625817
2.

Breath actuated device improves delivery to target sites beyond the nasal valve.

Djupesland PG, Skretting A, Winderen M, Holand T.

Laryngoscope. 2006 Mar;116(3):466-72.

PMID:
16540911
3.

Deposition of aerosols delivered by nasal route with jet and mesh nebulizers.

Vecellio L, De Gersem R, Le Guellec S, Reychler G, Pitance L, Le Pennec D, Diot P, Chantrel G, Bonfils P, Jamar F.

Int J Pharm. 2011 Apr 4;407(1-2):87-94. doi: 10.1016/j.ijpharm.2011.01.024. Epub 2011 Jan 21.

PMID:
21256943
4.

Comparison of in vitro and in vivo efficiencies of a novel unit-dose liquid aerosol generator and a pressurized metered dose inhaler.

Farr SJ, Warren SJ, Lloyd P, Okikawa JK, Schuster JA, Rowe AM, Rubsamen RM, Taylor G.

Int J Pharm. 2000 Mar 30;198(1):63-70.

PMID:
10722951
5.

Nasal deposition and clearance in man: comparison of a bidirectional powder device and a traditional liquid spray pump.

Djupesland PG, Skretting A.

J Aerosol Med Pulm Drug Deliv. 2012 Oct;25(5):280-9. doi: 10.1089/jamp.2011.0924. Epub 2012 Jan 17.

PMID:
22251061
6.

Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusion.

Sangwan S, Agosti JM, Bauer LA, Otulana BA, Morishige RJ, Cipolla DC, Blanchard JD, Smaldone GC.

J Aerosol Med. 2001 Summer;14(2):185-95.

PMID:
11681650
7.

Pulsating aerosols for drug delivery to the sinuses in healthy volunteers.

Möller W, Schuschnig U, Khadem Saba G, Meyer G, Junge-Hülsing B, Keller M, Häussinger K.

Otolaryngol Head Neck Surg. 2010 Mar;142(3):382-8. doi: 10.1016/j.otohns.2009.12.028.

PMID:
20172385
8.

In vitro evaluation of radio-labeled aerosol delivery via a variable-flow infant CPAP system.

Farney KD, Kuehne BT, Gibson LA, Nelin LD, Shepherd EG.

Respir Care. 2014 Mar;59(3):340-4. doi: 10.4187/respcare.01904. Epub 2013 Aug 6.

9.

Radioaerosol Pulmonary Deposition Using Mesh and Jet Nebulizers During Noninvasive Ventilation in Healthy Subjects.

Galindo-Filho VC, Ramos ME, Rattes CS, Barbosa AK, Brandão DC, Brandão SC, Fink JB, de Andrade AD.

Respir Care. 2015 Sep;60(9):1238-46. doi: 10.4187/respcare.03667. Epub 2015 Jun 23.

10.

Intrapulmonary distribution of deposited particles.

Brand P, Häussinger K, Meyer T, Scheuch G, Schulz H, Selzer T, Heyder J.

J Aerosol Med. 1999 Winter;12(4):275-84.

PMID:
10724642
11.

Nasally inhaled pulsating aerosols: lung, sinus and nose deposition.

Moller W, Saba GK, Haussinger K, Becker S, Keller M, Schuschnig U.

Rhinology. 2011 Aug;49(3):286-91. doi: 10.4193/Rhino10.268.

PMID:
21858257
12.

Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.

Laube BL, Geller DE, Lin TC, Dalby RN, Diener-West M, Zeitlin PL.

Respir Care. 2005 Nov;50(11):1438-44.

13.

Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy.

Golshahi L, Longest PW, Azimi M, Syed A, Hindle M.

Respir Care. 2014 Oct;59(10):1476-86. doi: 10.4187/respcare.02903. Epub 2014 Jun 10.

14.

Intranasal deposition of nebulized saline: a radionuclide distribution study.

Hwang PH, Woo RJ, Fong KJ.

Am J Rhinol. 2006 May-Jun;20(3):255-61.

PMID:
16871925
15.

Characterization of deposition from nasal spray devices using a computational fluid dynamics model of the human nasal passages.

Kimbell JS, Segal RA, Asgharian B, Wong BA, Schroeter JD, Southall JP, Dickens CJ, Brace G, Miller FJ.

J Aerosol Med. 2007 Spring;20(1):59-74.

PMID:
17388754
16.

Aerosol deposition in neonatal ventilation.

Dubus JC, Vecellio L, De Monte M, Fink JB, Grimbert D, Montharu J, Valat C, Behan N, Diot P.

Pediatr Res. 2005 Jul;58(1):10-4. Epub 2005 Mar 17.

PMID:
15774850
17.

[Comparative studies of airway deposition of 99mTc-DTPA aerosol particles among 4 different nebulizers by pulmonary scintillation method].

Yamaguchi H, Shiigai N, Mitsubayashi K, Oosika E, Okada F, Mitsubayashi T, Sasaki N, Iseya O, Miyamae T, Suzuki I, Akasaka T.

Arerugi. 1997 Oct;46(10):1052-7. Japanese.

PMID:
9404093
18.

The challenges of quantitative measurement of lung deposition using 99mTc-DTPA from delivery systems with very different delivery times.

Coates AL, Green M, Leung K, Louca E, Tservistas M, Chan J, Ribeiro N, Charron M.

J Aerosol Med. 2007 Fall;20(3):320-30.

PMID:
17894538
19.

Effect of particle size of dry powder mannitol on the lung deposition in healthy volunteers.

Glover W, Chan HK, Eberl S, Daviskas E, Verschuer J.

Int J Pharm. 2008 Feb 12;349(1-2):314-22. Epub 2007 Aug 19.

PMID:
17904774
20.

Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA.

Nikander K, Prince I, Coughlin S, Warren S, Taylor G.

J Aerosol Med Pulm Drug Deliv. 2010 Apr;23 Suppl 1:S37-43. doi: 10.1089/jamp.2009.0786.

Supplemental Content

Support Center